Abstract Background/Aims: Adenomyosis is a disease in which ectopic endometrial glands and stromal cells appear in the uterine myometrium. Despite its prevalence, the molecular mechanisms involved in the development of adenomyosis are largely unknown. The aim of this study was
MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation
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Introduction
Adenomyosis is a common, benign, gynecological disorder characterized by the invasion of endometrial epithelial cells into the myometrium of uterus. Adenomyosis can cause menorrhagia, dysmenorrhea, chronic pelvic pain, and preterm labor in women of reproductive age, and is associated with an increased risk of anemia [1, 2] . Substantial evidence indicates that adenomyosis is prompted and driven by the effects of estrogen [3] . Oestrogen-enhanced migratory and invasive properties of endometrial epithelial cells underlie the ability of the invasiveness of endometrial epithelial cells are not well understood.
MicroRNAs (miRNAs) are single-stranded noncoding RNAs of about 22 nucleotides that suppress the expression of target genes to regulate diverse cellular processes. Many miRNAs are implicated in tumor growth and metastasis [5] . Of these miRNAs, miR-10b is upregulated in a number of human cancers, promoting cancer cell migration and invasion [6] [7] [8] [9] [10] . However, miR-10b is found to be downregulated in endometrial cancers such as endometrial serous adenocarcinoma (ESA) and endometrioid endometrial carcinoma [11, overall survival in ESA [11] . These data suggest that, opposite of its oncogenic activity in other cancer types, miR-10b acts as a tumor suppressor in cancers of endometrium origin. MiR-10b is also found to be downregulated in endometriotic tissues of women with endometriosis [13] . In vitro studies reveal that miR-10b directly targets syndecan-1 to curb invasiveness of human endometriotic cells [14] , suggesting that miR-10b plays an inhibitory role in the development of endometriosis. However, the expression and function of miR-10b in adenomyosis, a condition closely related to endometriosis, have not been reported.
Epithelial-mesenchymal transition (EMT) is characterized by loss of cell-to-cell adhesion and increased cell motility, and is closely associated with the invasion and metastasis of several cancers [15] . One of the hallmarks of EMT is the down-regulation of E-cadherin, which is repressed by several transcription factors including ZEB1, ZEB2, SNAI1, SNAI2, Twist1, Twist2 and E12/E47 [16] . Interestingly, several recent studies have shown that E-cadherin expression is downregulated in epithelial component of human adenomyotic lesions, suggesting that EMT plays a crucial role in the development of adenomyosis [4, 17] . The PI3K/Akt survival pathway, which is activated by estrogen, is also implicated in the pathogenesis of adenomyosis [18, 19] . versus healthy controls. We subsequently investigated the function of miR-10b in the development of adenomyosis in the context of the migration and invasion of adenomyotic epithelial cells. Finally, we examined the regulatory relationship between miR-10b and putative target genes ZEB1 and PIK3CA and explored the involvement of E-cadherin and Akt, which act downstream of ZEB1 and PIK3CA in miR-10b-induced effects.
Materials and Methods

Patients and tissue collection
The study protocol was approved by the Ethics Review Board of JiangWan Hospital, Shanghai, China. The study was conducted in accordance with the Declaration of Helsinki and applicable regulations in China. All study participants gave written informed consent. 
Cellular Physiology and Biochemistry
Paired eutopic and ectopic endometrial tissues were collected from premenopausal women with adenomyosis (n = 22, 30 -39 years old) who underwent hysterectomy at JiangWan Hospital of Shanghai. These tissues were from different phases of the menstrual cycle. Normal endometrial tissues were collected from 13 premenopausal women without evidence of adenomyosis (n = 13, 29 -41 years old) who underwent hysterectomy for subserousal leiomyoma at the same hospital. Samples were immediately frozen and stored in liquid nitrogen until analysis.
Microarray and analysis
Fresh-frozen normal endometrial tissues and ectopic endometrial tissues of adenomyosis in TRIzol reagent were shipped to KangChen Bio-tech (Shanghai, China). MiRNAs were extracted, labeled, and hybridized to the Phalanx human miRNA OneArray (v5.1) containing probes for 1387 human miRNAs. Data were normalized using median normalization method. A heat map was created using Cluster 3.0 and JAVA Treeview software. All experiments and data analysis were carried out at KangChen Bio-tech.
Quantitative real time PCR
Total RNA was extracted from tissues and cells using Trizol reagent (Invitrogen, USA) according to the manufacturer's instructions. MiRNA cDNA was synthesized using a Mir-X miRNA First-Strand synthesis kit (Clontech, USA). Real-time quantitative PCR (qRT-PCR) was performed using a SYBR green qPCR kit (TaKaRa, Japan) on an Applied Biosystems 7300 QPCR System (Foster City, CA, USA). qRT-PCR was performed for 40 cycles (miRNAs: 95°C for 15 s and 60°C for 1 min after an initial 15 min incubation at 95°C; mRNAs: 95°C for 10 s and 72°C for 30 s after an initial 3 min incubation at 95°C). The data were analyzed according to the 2 method [20] , and the fold change in the expression of each miRNA or mRNA was normalized to RNU6B or GAPDH. Sequences of primers used in PCR are shown in Table 1 .
Isolation and culture of human endometrial epithelial cells
Freshly collected normal endometrium and paired eutopic and ectopic endometrial tissues were processed and separated into stromal and epithelial cell fractions following previously described procedures supplemented with 10% fetal bovine serum (FBS) at 37°C, 5% CO 2 
RNA oligoribonucleotides and plasmids
The shRNAs targeting human ZEB1 and PIK3CA transcripts were designated as shRNA-ZEB1 and shRNA-PIK3CA, respectively. The anti-miR-10b that had a sequence complementary to mature miR-10b was negative control anti-miR-NC, and miR-10b mimics (miR-10b) and negative control miR-NC mimics (miR-NC) were synthesized at Genepharma (Shanghai, P. R. China). All negative control RNAs had sequences that were non-homologous to any human genome sequences. 
Cell transfections
Endometrial epithelial cells isolated from ectopic endometrial tissues of adenomyosis patients were seeded in 12-well plates, cultured for 24 h, and then transfected with RNA oligoribonucleotides or plasmids. All transfections were performed using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. Cells were collected 48 h after transfection and used in subsequent studies.
Cell migration and invasion assays
Cell migration and Invasion assays were performed as previously described using uncoated and 4 serving as a chemoattractant. After 24 h incubation at 37°C, cells that had moved through the member and adhered to the lower surface of the membrane were counted under a microscope.
Luciferase reporter assay
Dual-Luciferase reporter assays (Promega, USA) were performed following manufacturer's instructions 
Statistical analysis
Data are interpreted using the GraphPad Prism 5 software (GraphPad Software, Inc, San Diego, CA). All results are presented as the mean ± SD (standard deviation). To determine statistical differences between two groups Student's t-test was used. ANOVA (one-way analysis of variance or repeated measures) was used with the post hoc Bonferroni's test for the comparison of more than two groups. Differences with a p value
Results
MiR-10b expression is downregulated in human adenomyosis
To identify miRNAs deregulated in human adenomysis, we analyzed the expression of 1387 miRNAs in human normal endometrium and ectopic endometrial lesions of adenomyosis using a microarray screen assay. Of the 156 miRNAs that showed differential endometrial lesions of adenomyosis versus normal endometrium (p<0.05) (Fig. 1B) . 
Cellular Physiology and Biochemistry
In particular, miR-10b, miR-371b-5p, miR-92b-5p, miR-30c, and miR-100 were most Fig. 1C and 1D ). Further qRT-PCR analysis showed that, compared with that in human normal endometrium, miR-10b expression progressively declined in paired human eutopic and ectopic endometrium of adenomyosis, although the expression difference between the
MiR-10b inhibits adenomyotic epithelial cell migration and invasion
Previous studies have reported that miR-1b is downregulated in human endometriosis [13] . Additionally, miR-10b functions to curb the invasiveness of human endometriotic epithelial cells [14] . Having found that miR-10b is also downregulated in human adenomyotic lesions, we proceeded to test the effects of miR-10b on the migration and invasion of adenomyotic epithelial cells. Our qRT-PCR results showed that miR-10b was expressed in endometrial epithelial cells isolated from normal endometrium with a progressive decline in expression in cells isolated from paired eutopic and ectopic endometrium of adenomyosis ( Fig. 2A) , and the rate of cell migration (Fig. 2B) and invasion (Fig. 2C ) was inversely correlated with the level of miR-10b expression. Furthermore, in endometrial epithelial cells isolated from the rate of cell migration and invasion (Fig. 2D-2F ). Taken together, these data suggest that 
MiR-10b downregulates ZEB1 and PIK3CA expression by directly targeting their 3'-UTRs
To explore the mechanisms underlying miR-10b-inudced inhibition of the migration and invasion of adenomyotic epithelial cells, we used computational algorithms to identify potential miR-10b target genes. Our in silico analyses using three target prediction softwares 10b in the 3'-UTRs of ZEB1 and PIK3CA. To test whether ZEB1 and PIK3CA are direct targets of miR-10b, we prepared luciferase reporter systems using the 3'-UTRs of human ZEB1 and PIK3CA, respectively, containing the putative miR-10b binding site (Fig. 3A) . We also created luciferase expression systems using mutant 3'-UTRs in which several nucleotides at the putative binding site were mutated to disrupt miR-10b binding (Fig. 3A) . Co-transfection of the luciferase reporter system containing the wild type 3'-UTR of ZEB1 or PIK3CA with compared with miR-NC (p<0.05, Fig. 3B ). However, luciferase expression was not affected by co-transfection with miR-10b when the wild type 3'-UTR was replaced with mutant 3'-UTR (Fig. 3B) . Further, in endometrial epithelial cells isolated suppressed protein expression of ZEB1 and PIK3CA, similar to that achieved with shRNAmediated gene knockdown (Fig. 3C) . Additionally, miR-10b silencing by anti-miR-10b (Fig. 3D) . Taken together, these results indicate that miR-10b downregulates ZEB1 and PIK3CA expression by directly targeting their 3'-UTRs.
ZEB1 and PIK3CA expression is upregulated in human adenomyosis
To explore the potential role of ZEB1 and PIK3CA in human adenomyosis, we analyzed their protein expression in human normal endometrium and paired eutopic and ectopic endometrial tissues of adenomyosis by immunohistochemical analysis. Visual examination of stained tissues revealed progressively increased protein expression of both ZEB1 and PIK3CA in paired human eutopic and ectopic endometrium of adenomyosis compared with assessment of protein expression using immunostaining scores (Fig. 4B) . qRT-PCR analysis revealed similar progressive increases in mRNA expression of ZEB1 and PIK3CA in these tissues (Fig. 4C) . Thus, ZEB1 and PIK3CA expression was upregulated in human adenomyosis and was inversely correlated with miR-10b expression, suggesting that they potentially play a role in the development of human adenomyosis. 
MiR-10b upregulates E-cadherin expression and inhibits Akt phosphorylation in adenomyotic epithelial cells
The cell-cell adhesion molecule E-cadherin and the PI3K/Akt pathway are implicated in the development of adenomyosis [4, [17] [18] [19] . E-cadherin is negatively regulated by E-cadherin and Akt might be involved in the mechanisms underlying miR-10b-induced effects on adenomyotic epithelial cells. Indeed, in endometrial epithelial cells isolated from ectopic endometrial tissues of adenomyosis, miR-10b overexpression-induced inhibition of cell migration and invasion was accompanied by increased E-cadherin expression and decreased Akt phosphorylation (Fig. 5A-5C ). ZEB1 and PIK3CA knockdown in these cells produced similar effects on E-cadherin expression and Akt phosphorylation, respectively, and diminished cell migration and invasion (Fig. 5A-5C ). Collectively, these data provided evidence that the ZEB1/E-cadherin and PI3K/Akt signaling pathways are involved in miR10b-induced inhibition of adenomyotic epithelial cell migration and invasion.
Discussion
MiRNAs have been implicated in endometriotic lesion development [25] , regulating and apoptosis, and angiogenesis [26] . In particular, miR-10b is downregulated in human endometriosis [13] and directly targets syndecan-1 to inhibit endometriotic epithelial cell invasiveness via downregulation of metalloproteinase activity and interleukin-6 [14] . However, the role of miR-10b in adenomyosis, a condition closely related to endometriosis, downregulated in human adenomyotic lesions and adenomyotic epithelial cells. Compared with normal endometrial tissues, eutopic and ectopic endometrial tissues of adenomyosis showed progressively declined miR-10b expression and progressively enhanced cell migration and invasion. Additionally, miR-10b overexpression reduced the migratory and invasive capacity of adenomyotic epithelial cells. To explore the mechanisms underlying these effects, we searched for potential targets of miR-10b and demonstrated that miR10b directly targets the 3'-UTRs of ZEB1 and PIK3CA using a luciferase reporter assay. We also showed that in adenomyotic epithelial cells, miR-10b overexpression downregulated ZEB1 and PIK3CA expression, leading to increased E-cadherin expression and reduced Akt phosphorylation. Collectively, these results suggest that miR-10b directly targets ZEB1 and PI3K to curb adenomyotic epithelial cell invasiveness via upregulation of E-cadherin and inhibition of Akt phosphorylation.
Adenomyosis is enigmatic in terms of etiology. Oestrogen-enhanced migratory and invasive properties of endometrial epithelial cells play a crucial role in the development of adenomyosis [3, 4] . Our results suggest that miR-10b inhibits the development of adenomyosis by curtailing the invasiveness of adenomyotic epithelial cells. To our knowledge, this is the is the sample size. It only comprised 22 adenomyosis patients and 13 control women. And be further investigated.
for adenomyosis is a hysterectomy. Uterus-sparing operative treatment is feasible but shows miR-10b may provide novel therapy for adenomyosis treatment. 
